Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
Gastrointest Endosc
; 65(3): 367-72, 2007 Mar.
Article
em En
| MEDLINE
| ID: mdl-17321232
ABSTRACT
BACKGROUND:
Approximately 20% of patients with GERD do not respond to medical therapy. The Stretta radiofrequency antireflux procedure represents an alternative to failed drug therapy for GERD.OBJECTIVE:
The aim of this study was to assess symptom and medication changes after the Stretta procedure during a 4-year follow-up period.DESIGN:
Prospective case series on intent-to-treat basis.SETTING:
Community practice. PATIENTS Patients with GERD with persistent symptoms despite twice-daily proton pump inhibitor (PPI) medications.INTERVENTIONS:
The Stretta procedure was performed in drug-refractory patients with GERD diagnosed by the presence of endoscopically evidenced esophagitis or abnormal esophageal pH testing. Symptom assessment was performed with a validated health-related quality-of-life questionnaire (with and without medication) at baseline and 6, 12, 24, 36, and 48 months after treatment. Complications of the procedure and medication usage were analyzed. MAIN OUTCOME MEASUREMENTS Significant changes in symptom scores, GERD quality-of-life parameters, and medication usage on the basis of clinical outcomes.RESULTS:
We report on a series of 109 consecutive patients treated with the Stretta procedure who have reached 4-year follow-up. Complete long-term follow-up assessment was available in matched data for 109 patients at 12 months, 108 patients at 24 months, 102 patients at 36 months, and 96 patients at 48 months. A second procedure was performed in 13 patients. Heartburn scores decreased from 3.6 to 1.18 (P < .001), total heartburn score (GERD health-related quality-of-life questionnaire) decreased from 27.8 to 7.1 (P < .001), and patient satisfaction improved from 1.4 to 3.8 (P < .001) (see ). Medication usage decreased significantly from 100% of patients on twice-daily PPI therapy at baseline to 75% of patients showing elimination of medications or only as-needed use of antacids/over-the-counter PPIs at 48 months (P < 0.005). There were no serious complications of the procedure.LIMITATIONS:
This is an uncontrolled, nonrandomized case series in consecutive patients that does not include long-term pH or motility studies.CONCLUSIONS:
This study in drug-refractory patients with GERD found the Stretta procedure to be a safe, effective, and durable treatment that produced significant improvements in heartburn and quality of life and decreased medication usage during a 4-year period of follow-up.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Qualidade de Vida
/
Refluxo Gastroesofágico
/
Ablação por Cateter
/
Inibidores Enzimáticos
/
Inibidores da Bomba de Prótons
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Gastrointest Endosc
Ano de publicação:
2007
Tipo de documento:
Article
País de afiliação:
Estados Unidos